Natural health product · NPN 80137729
Cortisol Essentials
Yes: licensed in Canada
The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.
Licence status Active; licensed January 10, 2025; licence last revised September 10, 2026.
- Natural Product Number (NPN)
- 80137729
- Licence holder
- Researched Nutritionals
- Dosage form
- Capsule
- Route
- Oral
- Licensing route
- General (non-traditional)
- First licensed
- January 10, 2025
- Licence last revised
- September 10, 2026
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| Bacopa monnieri | 75 mg | Bacopa monnieri - Whole Plant |
| Oryza sativa | 100 mg | Oryza sativa - Seed; 25 % Anthocyanins |
| Scutellaria lateriflora | 100 mg | Scutellaria lateriflora - Herb top |
| Withania somnifera | 62.5 mg | Withania somnifera - root; 5:1 Dry; equivalent to 312.5 mg dried herb |
| Withania somnifera | — | Withania somnifera - root |
| Hericium erinaceus | 250 mg | 10:1 Fresh; equivalent to 2500 mg dried herb |
| Cytidine 5'-diphosphocholine | 62.5 mg | Citicoline sodium |
| Phosphatidylserine | 25 mg | Helianthus annuus - Seed |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- Source of fungal polysaccharides with immunomodulating properties. Helps reduce cortisol and C reactive protein levels, biomarkers of physical stress. Helps reduce the symptoms of stress, such as fatigue, sleeplessness, irritability, and inability to concentrate. Source of antioxidants.
Non-medicinal ingredients
Hypromellose; L-Leucine